Cochrane · systematic review · CD012988

Exercise therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast cancer

Roberts, KE, Rickett, K, Feng, S, et al. · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library

Breast CancerAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 5 · 71.4%Low 2 · 28.6%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Exercise therapies compared to standard care for the management of aromatase inhibitor‐induced musculoskeletal symptoms

Population: women with aromatase inhibitor‐induced musculoskeletal symptoms (AIMSS)
7 questions
OutcomeEffectEvidenceStatus / GRADE
Overall change in worst pain scores
Exercise therapies vs standard care
no estimate extracted4 studies · 284 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, publication bias
Overall change in stiffness scores
Exercise therapies vs standard care
no estimate extracted1 study · 53 participantsLow
Downgraded: risk of bias, imprecision
Overall change in grip strength
Exercise therapies vs standard care
no estimate extracted1 study · 83 participantsVery low
Downgraded: risk of bias, imprecision, publication bias
Overall change in health‐related quality of life
Exercise therapies vs standard care
no estimate extracted2 studies · 123 participantsVery low
Downgraded: risk of bias, imprecision, publication bias
Overall change in cancer‐specific quality of life
Exercise therapies vs standard care
no estimate extracted2 studies · 136 participantsVery low
Downgraded: risk of bias, imprecision, publication bias
Adverse effects secondary to the intervention
Exercise therapies vs standard care
no estimate extracted4 studies · 331 participantsLow
Downgraded: risk of bias, imprecision
Adherence to aromatase inhibitors
Exercise therapies vs standard care
OR 2.43 [0.41, 14.63]2 studies · 224 participantsVery low
Downgraded: risk of bias, imprecision, publication bias